SCHEMBL31428705

SCHEMBL31428705

CC(=O)N1C(=Cc2ccc(OCC(N)=O)cc2)C(=O)c2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.61
▸ MAPT P10636 3/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ TDP1 Q9NUW8 2/20 0.61
▸ HTT P42858 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ CES1 P23141 1/20 0.45
▸ KDM4E B2RXH2 3/20 0.41
▸ HPGD P15428 1/20 0.41
▸ AKR1B1 P15121 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ CTDSP1 Q9GZU7 1/20 0.40
▸ AOC3 Q16853 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31429004 0.88 MAPT (0.53) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428668 0.84 ALDH1A1 (0.53) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL30163485 0.83 MAPT (0.53) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428526 0.83 ALDH1A1 (0.53) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428762 0.83 MAPT (0.47) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428729 0.83 ALDH1A1 (0.54) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428869 0.83 MAPT (0.44) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428577 0.82 ALDH1A1 (0.50) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428779 0.81 ALDH1A1 (0.50) ALDH1A1MAPTMAPK1TDP1HTT
SCHEMBL31428917 0.74 MAPT (0.52) ALDH1A1MAPTMAPK1TDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS ALDH1A1 2352/4885MAPT 4513/4885MAPK1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback